U.S Physical Therapy Long Term Debt 2012-2026 | USPH

U.S Physical Therapy long term debt from 2012 to 2026. Long term debt can be defined as the sum of all long term debt fields.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
U.S Physical Therapy Annual Long Term Debt
(Millions of US $)
2025 $153
2024 $143
2023 $139
2022 $176
2021 $118
2020 $17
2019 $50
2018 $38
2017 $57
2016 $51
2015 $48
2014 $35
2013 $41
2012 $18
2011 $24
U.S Physical Therapy Quarterly Long Term Debt
(Millions of US $)
2026-06-30 $215
2026-03-31 $194
2025-12-31 $153
2025-09-30 $151
2025-06-30 $152
2025-03-31 $157
2024-12-31 $143
2024-09-30 $133
2024-06-30 $136
2024-03-31 $137
2023-12-31 $139
2023-09-30 $141
2023-06-30 $143
2023-03-31 $183
2022-12-31 $176
2022-09-30 $147
2022-06-30 $149
2022-03-31 $122
2021-12-31 $118
2021-09-30 $35
2021-06-30 $39
2021-03-31 $17
2020-12-31 $17
2020-09-30 $8
2020-06-30 $34
2020-03-31 $119
2019-12-31 $50
2019-09-30 $55
2019-06-30 $66
2019-03-31 $30
2018-12-31 $38
2018-09-30 $55
2018-06-30 $57
2018-03-31 $43
2017-12-31 $57
2017-09-30 $60
2017-06-30 $73
2017-03-31 $63
2016-12-31 $51
2016-09-30 $41
2016-06-30 $47
2016-03-31 $57
2015-12-31 $48
2015-09-30 $48
2015-06-30 $42
2015-03-31 $42
2014-12-31 $35
2014-09-30 $47
2014-06-30 $45
2014-03-31 $46
2013-12-31 $41
2013-09-30 $15
2013-06-30 $16
2013-03-31 $21
2012-12-31 $18
2012-09-30 $16
2012-06-30 $20
2012-03-31 $25
2011-12-31 $24
2011-09-30 $27
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.220B $0.781B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $29.581B 13.26
Quest Diagnostics (DGX) United States $27.271B 23.22
DaVita (DVA) United States $12.179B 14.91
Encompass Health (EHC) United States $12.036B 20.89
Elanco Animal Health (ELAN) United States $11.491B 21.70
Chemed (CHE) United States $6.620B 23.60
RadNet (RDNT) United States $6.069B 175.27
LifeStance Health (LFST) United States $4.991B 100.46
Option Care Health (OPCH) United States $3.523B 14.89
Aveanna Healthcare Holdings (AVAH) United States $3.123B 21.68
Addus HomeCare (ADUS) United States $2.164B 19.57
Astrana Health (ASTH) United States $2.138B 22.69
Pennant (PNTG) United States $1.396B 36.34
Daxor (DXR) United States $0.065B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
Psychemedics (PMD) United States $0.000B 0.00